{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:56:39Z","timestamp":1793238999568,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370467"],"award-info":[{"award-number":["82370467"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10495-026-02264-8","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:58:57Z","timestamp":1769155137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["BMP7 attenuates myocardial injury and preserves cardiac function after myocardial infarction by inhibiting cardiomyocyte pyroptosis"],"prefix":"10.1007","volume":"31","author":[{"given":"Maojun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1430-4833","authenticated-orcid":false,"given":"Xinqun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"10065","key":"2264_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","volume":"389","author":"GW Reed","year":"2017","unstructured":"Reed GW, Rossi JE, Cannon CP (2017) Acute myocardial infarction. Lancet 389(10065):197\u2013210","journal-title":"Lancet"},{"issue":"16","key":"2264_CR2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/eurheartj\/ehaf056","volume":"46","author":"IB Squire","year":"2025","unstructured":"Squire IB, Sze S (2025) Prognosis following acute myocardial infarction. Eur Heart J 46(16):1551\u20131553","journal-title":"Eur Heart J"},{"key":"2264_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116079","volume":"170","author":"X Peng","year":"2024","unstructured":"Peng X, Du J, Wang Y (2024) Metabolic signatures in post-myocardial infarction heart failure, including insights into prediction, intervention, and prognosis. Biomed Pharmacother 170:116079","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"2264_CR4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s11886-022-01766-6","volume":"24","author":"MG Del Buono","year":"2022","unstructured":"Del Buono MG, Moroni F, Montone RA, Azzalini L, Sanna T, Abbate A (2022) Ischemic cardiomyopathy and heart failure after acute myocardial infarction. Curr Cardiol Rep 24(10):1505\u20131515","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"2264_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","volume":"6","author":"MC Bahit","year":"2018","unstructured":"Bahit MC, Kochar A, Granger CB (2018) Post-myocardial infarction heart failure. JACC Heart Fail 6(3):179\u2013186","journal-title":"JACC Heart Fail"},{"issue":"13","key":"2264_CR6","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1001\/jama.2015.2323","volume":"313","author":"Y Han","year":"2015","unstructured":"Han Y, Guo J, Zheng Y, Zang H, Su X, Wang Y et al (2015) Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial. JAMA 313(13):1336\u20131346","journal-title":"JAMA"},{"issue":"27","key":"2264_CR7","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","volume":"43","author":"S Frantz","year":"2022","unstructured":"Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J (2022) Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J 43(27):2549\u20132561","journal-title":"Eur Heart J"},{"issue":"3-4","key":"2264_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10495-025-02075-3","volume":"30","author":"H Wu","year":"2025","unstructured":"Wu H, Lan Q, He YX, Xue JY, Liu H, Zou Y et al (2025) Programmed cardiomyocyte death in myocardial infarction. Apoptosis 30(3\u20134):597\u2013615","journal-title":"Apoptosis"},{"issue":"4","key":"2264_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41569-023-00946-3","volume":"21","author":"S Toldo","year":"2024","unstructured":"Toldo S, Abbate A (2024) The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. Nat Rev Cardiol 21(4):219\u2013237","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2264_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X (2021) Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 6(1):128","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"2264_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","volume":"180","author":"K Wang","year":"2020","unstructured":"Wang K, Sun Q, Zhong X, Zeng M, Zeng H, Shi X et al (2020) Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell 180(5):941\u201355.e20","journal-title":"Cell"},{"issue":"9","key":"2264_CR12","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","volume":"11","author":"BE Burdette","year":"2021","unstructured":"Burdette BE, Esparza AN, Zhu H, Wang S (2021) Gasdermin D in pyroptosis. Acta Pharm Sin B 11(9):2768\u20132782","journal-title":"Acta Pharm Sin B"},{"key":"2264_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yjmcc.2022.07.005","volume":"171","author":"Y Gao","year":"2022","unstructured":"Gao Y, Shi H, Dong Z, Zhang F, Sun A, Ge J (2022) Current knowledge of pyroptosis in heart diseases. J Mol Cell Cardiol 171:81\u201389","journal-title":"J Mol Cell Cardiol"},{"key":"2264_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176464","volume":"971","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li X, Sun T, Li T, Li Q (2024) Pyroptosis in myocardial ischemia\/reperfusion and its therapeutic implications. Eur J Pharmacol 971:176464","journal-title":"Eur J Pharmacol"},{"key":"2264_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1357285","volume":"15","author":"R Bhatti","year":"2024","unstructured":"Bhatti R, Sato PY (2024) Exploring the role of pyroptosis in the pathogenicity of heart disease. Front Physiol 15:1357285","journal-title":"Front Physiol"},{"issue":"3","key":"2264_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/CIRCRESAHA.120.318629","volume":"129","author":"H Shi","year":"2021","unstructured":"Shi H, Gao Y, Dong Z, Yang J, Gao R, Li X et al (2021) GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I\/R injury. Circ Res 129(3):383\u2013396","journal-title":"Circ Res"},{"issue":"10","key":"2264_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04143-3","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Shen J, Li Y, Wu J, Luo X, Yu Y et al (2021) Pyroptosis inhibition improves the symptom of acute myocardial infarction. Cell Death Dis 12(10):852","journal-title":"Cell Death Dis"},{"issue":"2","key":"2264_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/iyad200","volume":"226","author":"T Akiyama","year":"2024","unstructured":"Akiyama T, Raftery LA, Wharton KA (2024) Bone morphogenetic protein signaling: the pathway and its regulation. Genetics 226(2):iyad200","journal-title":"Genetics"},{"issue":"1","key":"2264_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/path.5170","volume":"247","author":"MC Gomez-Puerto","year":"2019","unstructured":"Gomez-Puerto MC, Iyengar PV, de Garc\u00eda Vinuesa A, Ten Dijke P, Sanchez-Duffhues G (2019) Bone morphogenetic protein receptor signal transduction in human disease. J Pathol 247(1):9\u201320","journal-title":"J Pathol"},{"key":"2264_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1125642","volume":"14","author":"D Ye","year":"2023","unstructured":"Ye D, Liu Y, Pan H, Feng Y, Lu X, Gan L et al (2023) Insights into bone morphogenetic proteins in cardiovascular diseases. Front Pharmacol 14:1125642","journal-title":"Front Pharmacol"},{"issue":"3","key":"2264_CR21","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1042\/BST20231547","volume":"52","author":"W Li","year":"2024","unstructured":"Li W, Quigley K (2024) Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection. Biochem Soc Trans 52(3):1515\u20131528","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"2264_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.117.031635","volume":"138","author":"KJ Morine","year":"2018","unstructured":"Morine KJ, Qiao X, York S, Natov PS, Paruchuri V, Zhang Y et al (2018) Bone morphogenetic protein 9 reduces cardiac fibrosis and improves cardiac function in heart failure. Circulation 138(5):513\u2013526","journal-title":"Circulation"},{"issue":"2","key":"2264_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031989","volume":"10","author":"MJ Goumans","year":"2018","unstructured":"Goumans MJ, Zwijsen A, Ten Dijke P, Bailly S (2018) Bone morphogenetic proteins in vascular homeostasis and disease. Cold Spring Harb Perspect Biol 10(2):a031989","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"21","key":"2264_CR24","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.123.065935","volume":"150","author":"Z Duan","year":"2024","unstructured":"Duan Z, Huang Z, Lei W, Zhang K, Xie W, Jin H et al (2024) Bone morphogenetic protein 9 protects against myocardial infarction by improving lymphatic drainage and triggering DECR1-mediated mitochondrial bioenergetics. Circulation 150(21):1684\u20131701","journal-title":"Circulation"},{"issue":"6","key":"2264_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1296","volume":"13","author":"G Lu","year":"2023","unstructured":"Lu G, Ge Z, Chen X, Ma Y, Yuan A, Xie Y et al (2023) BMP6 knockdown enhances cardiac fibrosis in a mouse myocardial infarction model by upregulating AP-1\/CEMIP expression. Clin Transl Med 13(6):e1296","journal-title":"Clin Transl Med"},{"issue":"2","key":"2264_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020280","volume":"9","author":"C Aluganti Narasimhulu","year":"2020","unstructured":"Aluganti Narasimhulu C, Singla DK (2020) The role of bone morphogenetic protein 7 (BMP-7) in inflammation in heart diseases. Cells 9(2):280","journal-title":"Cells"},{"issue":"3","key":"2264_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/cvr\/cvw076","volume":"110","author":"D Merino","year":"2016","unstructured":"Merino D, Villar AV, Garc\u00eda R, Tramullas M, Ruiz L, Ribas C et al (2016) BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery. Cardiovasc Res 110(3):331\u2013345","journal-title":"Cardiovasc Res"},{"issue":"6613","key":"2264_CR28","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1126\/science.abn0910","volume":"377","author":"Y Cao","year":"2022","unstructured":"Cao Y, Wang Y, Zhou Z, Pan C, Jiang L, Zhou Z et al (2022) Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure. Science 377(6613):1399\u20131406","journal-title":"Science"},{"issue":"1","key":"2264_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00623-8","volume":"29","author":"XJ Yu","year":"2023","unstructured":"Yu XJ, Wang YG, Lu R, Guo XZ, Qu YK, Wang SX et al (2023) BMP7 ameliorates intervertebral disc degeneration in type 1 diabetic rats by inhibiting pyroptosis of nucleus pulposus cells and NLRP3 inflammasome activity. Mol Med 29(1):30","journal-title":"Mol Med"},{"issue":"10","key":"2264_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102640","volume":"10","author":"I Elmadbouh","year":"2021","unstructured":"Elmadbouh I, Singla DK (2021) BMP-7 attenuates inflammation-induced pyroptosis and improves cardiac repair in diabetic cardiomyopathy. Cells 10(10):2640","journal-title":"Cells"},{"issue":"11","key":"2264_CR31","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.jcmg.2024.03.012","volume":"17","author":"MC Gissler","year":"2024","unstructured":"Gissler MC, Antiochos P, Ge Y, Heydari B, Gr\u00e4ni C, Kwong RY (2024) Cardiac magnetic resonance evaluation of LV remodeling post-myocardial infarction: prognosis, monitoring and trial endpoints. JACC Cardiovasc Imaging 17(11):1366\u20131380","journal-title":"JACC Cardiovasc Imaging"},{"issue":"25","key":"2264_CR32","first-page":"01394","volume":"S0140\u20136736","author":"JA Udell","year":"2025","unstructured":"Udell JA, Bahit MC, Campbell P, Butler J, Chopra VK, Bay\u00e9s-Gen\u00eds A et al (2025) Prevention of heart failure after acute myocardial infarction. Lancet S0140\u20136736(25):01394\u201301397","journal-title":"Lancet"},{"key":"2264_CR33","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.2741\/3583","volume":"14","author":"R Weiskirchen","year":"2009","unstructured":"Weiskirchen R, Meurer SK, Gressner OA, Herrmann J, Borkham-Kamphorst E et al (2009) Bmp-7 as antagonist of organ fibrosis. Front Biosci (Landmark Ed) 14:4992\u20135012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2264_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00114","volume":"6","author":"RX Li","year":"2015","unstructured":"Li RX, Yiu WH, Tang SC (2015) Role of bone morphogenetic protein-7 in renal fibrosis. Front Physiol 6:114","journal-title":"Front Physiol"},{"issue":"5","key":"2264_CR35","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/gut.2006.092460","volume":"56","author":"K Kinoshita","year":"2007","unstructured":"Kinoshita K, Iimuro Y, Otogawa K, Saika S, Inagaki Y, Nakajima Y et al (2007) Adenovirus-mediated expression of Bmp-7 suppresses the development of liver fibrosis in rats. Gut 56(5):706\u2013714","journal-title":"Gut"},{"key":"2264_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cbi.2015.11.012","volume":"243","author":"D Liang","year":"2016","unstructured":"Liang D, Wang Y, Zhu Z, Yang G, An G, Li X et al (2016) Bmp-7 attenuated silica-induced pulmonary fibrosis through modulation of the balance between TGF-\u03b2\/Smad and Bmp-7\/Smad signaling pathway. Chem Biol Interact 243:72\u201381","journal-title":"Chem Biol Interact"},{"key":"2264_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1629016","volume":"12","author":"Y Niu","year":"2025","unstructured":"Niu Y, Wang L, Zhang Y, Zou Y, Zhou C (2025) Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications. Front Cardiovasc Med 12:1629016","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2264_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70357","volume":"29","author":"C Piamsiri","year":"2025","unstructured":"Piamsiri C, Maneechote C, Chattipakorn SC, Chattipakorn N (2025) Therapeutic potential of gasdermin D-mediated myocardial pyroptosis in ischaemic heart disease: expanding the paradigm from bench to clinical insights. J Cell Mol Med 29(3):e70357","journal-title":"J Cell Mol Med"},{"key":"2264_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550226","volume":"16","author":"B Mo","year":"2025","unstructured":"Mo B, Ding Y, Ji Q (2025) Nlrp3 inflammasome in cardiovascular diseases: an update. Front Immunol 16:1550226","journal-title":"Front Immunol"},{"issue":"Pt 1","key":"2264_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.128558","volume":"257","author":"Y Sun","year":"2024","unstructured":"Sun Y, Chu S, Wang R, Xia R, Sun M, Gao Z et al (2024) Non-coding RNAs modulate pyroptosis in myocardial ischemia-reperfusion injury: a comprehensive review. Int J Biol Macromol 257(Pt 1):128558","journal-title":"Int J Biol Macromol"},{"issue":"18","key":"2264_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25189793","volume":"25","author":"S Msweli","year":"2024","unstructured":"Msweli S, Pakala SB, Syed K (2024) NF-\u03baB transcription factors: their distribution, family expansion, structural conservation, and evolution in animals. Int J Mol Sci 25(18):9793","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2264_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H (2020) Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5(1):209","journal-title":"Signal Transduct Target Ther"},{"key":"2264_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1252942","volume":"11","author":"R Chai","year":"2023","unstructured":"Chai R, Ye Z, Xue W, Shi S, Wei Y, Hu Y et al (2023) Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4\/NF-\u03baB p65 pathway after acute myocardial infarction. Front Cell Dev Biol 11:1252942","journal-title":"Front Cell Dev Biol"},{"key":"2264_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119563","volume":"344","author":"J Xu","year":"2025","unstructured":"Xu J, Kang L, Tai B, Liu C, Zhang Z, Ding Q et al (2025) The stems of Syringa oblata Lindl. exert cardioprotective effects against acute myocardial ischemia by inhibiting the TLR4\/MyD88\/NF-\u03baB and NLRP3 inflammasome signaling pathways in mice. J Ethnopharmacol 344:119563","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"2264_CR45","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ni.3772","volume":"18","author":"IS Afonina","year":"2017","unstructured":"Afonina IS, Zhong Z, Karin M, Beyaert R (2017) Limiting inflammation: the negative regulation of NF-\u03baB and the NLRP3 inflammasome. Nat Immunol 18(8):861\u2013869","journal-title":"Nat Immunol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02264-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:02:23Z","timestamp":1774080143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02264-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2264"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02264-8","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study adhered to the ethical principles established by the World Medical Association\u2019s Declaration of Helsinki for medical research involving human subjects and was approved by the Ethics Committee of the Second Xiangya Hospital of Central South University (Approval No.: LYF2023027). All patients provided consent to participate in this study. All animal and cell experiments in this study were approved by the Laboratory Animal Center of the Second Xiangya Hospital of Central South University (Approval No.: 20250919).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"57"}}